Reveles Xavier Trinidad 4
4 · bioAffinity Technologies, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Reveles Xavier Trinidad
Chief Operating Officer
Transactions
- Award
Common Stock
2024-01-31+16,720→ 20,339 total
Footnotes (1)
- [F1]Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.